Interpreting cost-effectiveness in dialysis: can the most expensive be more expensive?
In this issue, Tonelli et al. describe the cost-effectiveness of arteriovenous fistulae (AVF) screening, and conclude that such a program represents "good value for money." Here, I examine the robustness of this conclusion by considering traditional definitions of acceptable cost-effectiveness and more pragmatic definitions, which include consideration of the maximum amount that society would be willing to pay for hemodialysis.